Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Byron Berenger and Kanti Pabbaraju.
Byron Berenger
Connection Strength
0.291
Kanti Pabbaraju
  1. Acceptable performance of the Abbott ID NOW among symptomatic individuals with confirmed COVID-19. J Med Microbiol. 2021 Jul; 70(7).
    View in: PubMed
    Score: 0.060
  2. Clinical performance of the Abbott Panbio with nasopharyngeal, throat, and saliva swabs among symptomatic individuals with COVID-19. Eur J Clin Microbiol Infect Dis. 2021 Aug; 40(8):1721-1726.
    View in: PubMed
    Score: 0.058
  3. Extensive environmental contamination and prolonged severe acute respiratory coronavirus-2 (SARS CoV-2) viability in immunosuppressed recent heart transplant recipients with clinical and virologic benefit with remdesivir. Infect Control Hosp Epidemiol. 2021 Mar 12; 1-3.
    View in: PubMed
    Score: 0.058
  4. False negative rate of COVID-19 PCR testing: a discordant testing analysis. Virol J. 2021 01 09; 18(1):13.
    View in: PubMed
    Score: 0.058
  5. Optimization and clinical validation of dual-target RT-LAMP for SARS-CoV-2. J Virol Methods. 2020 12; 286:113972.
    View in: PubMed
    Score: 0.056
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.